These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 28752076)

  • 1. Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy.
    Asgharzadeh MR; Barar J; Pourseif MM; Eskandani M; Jafari Niya M; Mashayekhi MR; Omidi Y
    Bioimpacts; 2017; 7(2):115-133. PubMed ID: 28752076
    [No Abstract]   [Full Text] [Related]  

  • 2. Dysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy.
    Barar J; Omidi Y
    Bioimpacts; 2013; 3(4):149-62. PubMed ID: 24455478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renewed interests in carbonic anhydrase IX in relevance to breast cancer treatment.
    Dolatkhah M; Omidi Y
    Bioimpacts; 2019; 9(4):195-197. PubMed ID: 31799155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor acidity, chemoresistance and proton pump inhibitors.
    De Milito A; Fais S
    Future Oncol; 2005 Dec; 1(6):779-86. PubMed ID: 16556057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of tumour pH on cancer progression: strategies for clinical intervention.
    Ward C; Meehan J; Gray ME; Murray AF; Argyle DJ; Kunkler IH; Langdon SP
    Explor Target Antitumor Ther; 2020; 1(2):71-100. PubMed ID: 36046070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines.
    Omidi Y; Barar J
    Bioimpacts; 2014; 4(2):55-67. PubMed ID: 25035848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton channels and exchangers in cancer.
    Spugnini EP; Sonveaux P; Stock C; Perez-Sayans M; De Milito A; Avnet S; Garcìa AG; Harguindey S; Fais S
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2715-26. PubMed ID: 25449995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy.
    Iessi E; Logozzi M; Mizzoni D; Di Raimo R; Supuran CT; Fais S
    Metabolites; 2017 Dec; 8(1):. PubMed ID: 29295495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells.
    Parks SK; Cormerais Y; Durivault J; Pouyssegur J
    Oncotarget; 2017 Feb; 8(6):10225-10237. PubMed ID: 28055960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of pH Regulatory Proteins and Dysregulation of pH in Prostate Cancer.
    Fliegel L
    Rev Physiol Biochem Pharmacol; 2022; 182():85-110. PubMed ID: 32776252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Na+-H+ exchanger, pH regulation and cancer.
    Reshkin SJ; Cardone RA; Harguindey S
    Recent Pat Anticancer Drug Discov; 2013 Jan; 8(1):85-99. PubMed ID: 22738122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction.
    McDonald PC; Chafe SC; Dedhar S
    Front Cell Dev Biol; 2016; 4():27. PubMed ID: 27066484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of pH regulators in the diagnosis, prognosis and treatment of cancer.
    Granja S; Tavares-Valente D; Queirós O; Baltazar F
    Semin Cancer Biol; 2017 Apr; 43():17-34. PubMed ID: 28065864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-7/TGF-
    Su T; Huang S; Zhang Y; Guo Y; Zhang S; Guan J; Meng M; Liu L; Wang C; Yu D; Kwan HY; Huang Z; Huang Q; Lai-Han Leung E; Hu M; Wang Y; Liu Z; Lu L
    Acta Pharm Sin B; 2022 Feb; 12(2):821-837. PubMed ID: 35251919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs--an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research.
    Harguindey S; Arranz JL; Polo Orozco JD; Rauch C; Fais S; Cardone RA; Reshkin SJ
    J Transl Med; 2013 Nov; 11():282. PubMed ID: 24195657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
    Li W; Sun X
    Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the Proton Transport Pathway in Oral Squamous Cell Carcinoma: State of the Art and Theranostics Implications.
    Lorenzo-Pouso AI; Pérez-Sayáns M; Rodríguez-Zorrilla S; Chamorro-Petronacci C; García-García A
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor microenvironment conditions alter Akt and Na
    Pedersen AK; Mendes Lopes de Melo J; Mørup N; Tritsaris K; Pedersen SF
    BMC Cancer; 2017 Aug; 17(1):542. PubMed ID: 28806945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arecoline Increases Glycolysis and Modulates pH Regulator Expression in HA22T/VGH Hepatoma Cells, Leading to Increase of Intracellular Ca
    Cheng HL; Chang WT; Hu YC; Hsieh BS; Huang TC; Chong IW; Huang LW; Chang KL
    J Cancer; 2017; 8(16):3173-3182. PubMed ID: 29158789
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review).
    Naser R; Fakhoury I; El-Fouani A; Abi-Habib R; El-Sibai M
    Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36579669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.